Srs Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Mumbai, Maharashtra, India, established in 2001.
2001 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Srs Pharmaceuticals Private Limited

Srs Pharmaceuticals Private Limited, a active private limited company, was established on 27 March 2001 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24239MH2001PTC131384. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹5.00 Cr.

It upholds a compliant status. Employing 87 professional, Its leadership includes Pooja Ketan Deshpande (Director), Suchet Shyamsunder Rastogi (Director), Anuradha Ganesh Naik (Additional Director). Past directors included Mahika Suchet Rastogi, Kajol Gaurav Somani, Aman Singh Siwach. It holds ₹18.75 Cr open charges and ₹12.00 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 504 Marathon Max Bldg No.2, Mulund-Goregoan Link, L.B.S Marg, Mulund West Mumbai Mh 400080, In, Mumbai, Maharashtra, 400080.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24239MH2001PTC131384

  • Registration Number

    131384

  • Incorporation Date

    27 March 2001

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹5.00 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 5.00 Cr
  • Company Age 25 Year, 2 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 18.75 Cr
  • Satisfied Charges ₹ 12.00 Cr
  • Revenue Growth **** -69.94%
  • Profit Growth **** -95.30%
  • Ebitda **** -15.29%
  • Net Worth 4.37%
  • Total Assets **** 6.70%
Company report

Srs Pharmaceuticals Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Srs Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Srs Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Pooja Ketan Deshpande Director 10 Jun 2024 Current
Suchet Shyamsunder Rastogi Director 27 Mar 2001 Current
Anuradha Ganesh Naik Additional Director 30 Apr 2025 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 24 Oct 2016 Past
Pramod Abcsdd Company Secretary - Past
Pramod Abcsdd Director 01 Feb 2020 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 31 Dec 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Srs Pharmaceuticals.

Srs Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 69.94% decrease. The company also saw a substantial fall in profitability, with a 95.3% decrease in profit. The company's net worth moved up by a moderate rise of 4.37%.

Srs Pharmaceuticals revenue growth over time
Srs Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -69.94%
*******
*******
*******
*******
Revenue from Operations
*******
 -2.98%
*******
*******
*******
*******
Total Assets
*******
 6.70%
*******
*******
*******
*******
Profit or Loss
*******
 -95.30%
*******
*******
*******
*******
Net Worth
*******
 4.37%
*******
*******
*******
*******
EBITDA
*******
 -15.29%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Srs Pharmaceuticals?

In 2023, Srs Pharmaceuticals had a promoter holding of 99.00% and a public holding of 1.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹187,500,000.00

Satisfied Charges

₹120,000,000.00

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 10.75 Cr
  • Standard Chartered Bank : 8.00 Cr
Latest Charge Details
Date Lender Amount Status
07 Nov 2025 Hdfc Bank Limited ₹7.50 M Open
03 Sep 2024 Hdfc Bank Limited ₹10.00 Cr Open
15 Dec 2009 Standard Chartered Bank ₹8.00 Cr Open
16 Sep 2015 Standard Chartered Bank ₹1.50 M Satisfied
06 Jan 2005 Standard Chartered Bank ₹11.25 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Srs Pharmaceuticals?

Srs Pharmaceuticals has a workforce of 87 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Srs Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Srs Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Srs Pharmaceuticals
Recent Activity within the Organization
  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.75 Cr with Charge ID 101195938 was registered on 07 Nov 2025. was completed.

  • Annual General Meeting

    Srs Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Charges

    Progress on A charge registered on 16 Sep 2015 via Charge ID 10591262 with Standard Chartered Bank was fully satisfied on 12 Sep 2025. was documented.

  • Charges

    A charge registered on 06 Jan 2005 via Charge ID 90149601 with Standard Chartered Bank was fully satisfied on 12 Sep 2025. was recorded as a recent event.

  • Director Appointment

    Progress on Anuradha Ganesh Naik was appointed as a Additional Director was appointed as a Additional Director on 30 Apr 2025 & has been associated with this company since 1 year 1 month . was documented.

  • Balance Sheet

    Progress on Srs Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Srs Pharmaceuticals Private Limited?

The CIN of Srs Pharmaceuticals Private Limited is U24239MH2001PTC131384.

Where is Srs Pharmaceuticals Private Limited headquartered?

Srs Pharmaceuticals Private Limited is headquartered at 504 Marathon Max Bldg No.2, Mulund-Goregoan Link, L.B.S Marg, Mulund West Mumbai Mh 400080, In, Mumbai, Maharashtra, 400080.

When was Srs Pharmaceuticals Private Limited incorporated?

Srs Pharmaceuticals Private Limited was incorporated on 27 March 2001.

Who are the current directors of Srs Pharmaceuticals Private Limited?

The current directors of Srs Pharmaceuticals Private Limited are

What is the primary industry of Srs Pharmaceuticals Private Limited?

The primary industry of Srs Pharmaceuticals Private Limited is Manufacturing.

Is Srs Pharmaceuticals Private Limited a listed company?

Srs Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Srs Pharmaceuticals Private Limited?

The authorized capital of Srs Pharmaceuticals Private Limited is ₹5.00 Cr, and the paid-up capital is ₹5.00 Cr.

What is the compliance status of Srs Pharmaceuticals Private Limited?

The compliance status of Srs Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available